BIOFIRE® FILMARR...
17th February 2025 Content supplied by: bioMérieux (Clinical Diagnostics)
bioMérieux Gets FDA Approval for BIOFIRE® FILMARRAY® Gastrointestinal Panel Mid
BIOFIRE FILMARRAY © bioMérieux - Inserting a pouch into a multiplex PCR system
The recently FDA-approved BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, a PCR-based diagnostic tool, can detect 11 different pathogens simultaneously from stool specimens of patients showing signs and/or symptoms of gastrointestinal infection. Compatible with bioMérieux's BIOFIRE® FILMARRAY® 2.0 and Torch PCR systems, this test requires a minimal setup time of 2 minutes and delivers results in approximately 1 hour.
This innovative panel enhances bioMérieux's BIOFIRE® GI portfolio. It represents a modified version of the current comprehensive BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel, which identifies 22 pathogens and has been available since 2014, offering laboratories efficient processing with rapid, detailed results that enhance diagnostic accuracy and patient care outcomes.
BIOFIRE® Gastrointestinal (GI) Panel Mid will be released for commercial use in the United States by mid-2025.
Tags:
Date Published: 17th February 2025
Source article link: View
BIOFIRE® FILMARRAY® Tropical
bioMérieux (Clinical Diagnostics)
Address:
Marcy L'Etoile
France
Related news from bioMérieux (Clinical Diagnostics)
- BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel Receives FDA Clearance
- BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel Mini Receives FDA Special Clearance and CLIA Waiver
- bioMérieux's AST System VITEK® REVEAL Achieves FDA 510(k) Clearance
- FDA Clearance and CLIA-waiver for bioMerieux's BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
- US FDA CLIA-waiver for BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
- BioFire Defense Partners With BARDA
- FDA Clearance and CLIA-waiver for Fast and Innovative BIOFIRE® SPOTFIRE® POC System
- MAESTRIA™, a New Generation Microbiology Middleware Optimizes Laboratory Workflow
- VIDAS® KUBE™ - the Next-generation VIDAS® System Receives CE Marking
- FDA Breakthrough Device Designation for SPECIFIC REVEAL® Rapid AST System
- Added Medical Value with Urine Sample Results Up to 8 Hours Faster
- bioMérieux to Distribute Specific Diagnostics’ REVEAL Rapid AST System in Europe
- Enhanced BIOFIRE® Blood Culture Identification 2 (BCID2) Panel Submitted for FDA Clearance
- Spotlight on Antimicrobial Stewardship with bioMérieux
- New FDA Clearance for VITEK® MS: Expanded ID for Challenging Pathogens
- PhenoMATRIX™ for WASPLab®: AI for Sample Interpretation & Sorting
- BIOFIRE® FILMARRAY® Pneumonia Panels Gain FDA clearance and CE Marking
- bioMérieux and DIAGNOSTICS IS POWER at ECCMID 2018
- FDA Clears Identification of Mycobacteria, Nocardia and Moulds on VITEK® MS
- FDA Clearance for BacT/ALERT® VIRTUO™ Fully Automated Blood Culture System